Clinical Trial

DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma

Name: DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma — clinical trial record (NCT06158269)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Evaluate the efficacy of DVRd in patients with newly diagnosed double-hit multiple myeloma (MM) and the feasibility of minimal residual disease (MRD) guided maintenance therapy

Trial Details

NCT Number	NCT06158269
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Multiple Myeloma
Enrollment	40 participants
Start Date	2023-12
Primary Completion	2026-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2023-12-06